| abstract |
The invention relates to a method for treating a progesterone-dependent condition selected from the group consisting of endometriosis and related pain, adenomyosis, ovarian endometriosis, dysmenorrhea, fibromyomas, endometrial hyperproliferation, cervical cancer and cervical cancer, including intravaginal administration of a mucoadhesive capsule, which contains 85 up to 90% by weight of pullulan, and a capsule filling composition containing a selective progesterone receptor modulator (SPRM) and one or more excipients, where the mucoadhesive capsule e comprises a solubility-improving agent. |